Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
The clinical condition in which any part of the placenta invades and is inseparable from the uterine wall. (reVITALize)
Biomarker and diagnostic research for placenta accreta has been reported in the published literature.
32 clinical trials registered, 8 recruiting. Interventions under study include other interventions, procedural interventions, and medical devices. Pipeline includes 17 NA. Research is primarily sponsored by academic and government institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT06620432](https://clinicaltrials.gov/study/NCT06620432) |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 11:07 AM UTC
European rare disease database
High vs. Low Segmental Hysterotomy: Impact on Uterine Wall Defects Post-Cesarean |
NA |
Fundacion Clinica Valle del Lili |
RECRUITING |
[NCT06833606](https://clinicaltrials.gov/study/NCT06833606) | Diagnosis and Outcomes of Placental Accretism | — | IRCCS Azienda Ospedaliero-Universitaria di Bologna | RECRUITING |
[NCT04866888](https://clinicaltrials.gov/study/NCT04866888) | Placenta Accreta Spectrum Outcome After Uterine Conservation | NA | Alexandria University | RECRUITING |
[NCT07283042](https://clinicaltrials.gov/study/NCT07283042) | Evaluation of Clinical Outcomes and Acceptability of an Anatomical Classification for Placenta Accreta Spectrum | — | University of California, Los Angeles | RECRUITING |
[NCT06512181](https://clinicaltrials.gov/study/NCT06512181) | Uterine Preservation in the Management of Placenta Accreta Spectrum Disorders | NA | University of Pennsylvania | RECRUITING |
248 publications have been identified in PubMed for placenta accreta. Research spans Review / Meta-Analysis (27%), Epidemiology / Natural History (21%), and Diagnostic / Biomarker (16%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 53 | 27% |
Disease patterns and progression | 42 | 21% |
Testing and diagnosis research | 32 | 16% |
Clinical study results | 29 | 15% |
Laboratory research | 26 | 13% |
Patient case studies | 10 | 5% |
Other research | 6 | 3% |
New treatment approaches | 1 | 1% |
Verde F (2026). [PMID: 42070423](https://pubmed.ncbi.nlm.nih.gov/42070423/). *Eur J Radiol*. [Other]
Theisen ACW (2026). [PMID: 41757836](https://pubmed.ncbi.nlm.nih.gov/41757836/). *JBRA assisted reproduction*. [Review / Meta-Analysis]
Karunaratne MS (2026). [PMID: 40693354](https://pubmed.ncbi.nlm.nih.gov/40693354/). *Int J Gynaecol Obstet*. [Epidemiology / Natural History]
Vladic Stjernholm Y (2026). [PMID: 41885117](https://pubmed.ncbi.nlm.nih.gov/41885117/). *Lakartidningen*. [Review / Meta-Analysis]
Zullino S (2026). [PMID: 41690192](https://pubmed.ncbi.nlm.nih.gov/41690192/). *Eur J Obstet Gynecol Reprod Biol*. [Epidemiology / Natural History]
Wright A (2026). [PMID: 42121103](https://pubmed.ncbi.nlm.nih.gov/42121103/). *BMC Pregnancy Childbirth*. [Clinical Trial Publication]
Kim S (2026). [PMID: 42213622](https://pubmed.ncbi.nlm.nih.gov/42213622/). *PLoS One*. [Diagnostic / Biomarker]
Bartels HC (2026). [PMID: 40590446](https://pubmed.ncbi.nlm.nih.gov/40590446/). *Int J Gynaecol Obstet*. [Diagnostic / Biomarker]
Kasraeian M (2026). [PMID: 41987128](https://pubmed.ncbi.nlm.nih.gov/41987128/). *BMC Pregnancy Childbirth*. [Epidemiology / Natural History]
Mouna A (2026). [PMID: 42181454](https://pubmed.ncbi.nlm.nih.gov/42181454/). *Cureus*. [Case Report / Case Series]